Intuitive Surgical, Inc. $ISRG Stock Position Increased by Livforsakringsbolaget Skandia Omsesidigt

by · The Cerbat Gem

Livforsakringsbolaget Skandia Omsesidigt raised its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) by 1,295.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 119,223 shares of the medical equipment provider’s stock after purchasing an additional 110,680 shares during the quarter. Intuitive Surgical accounts for 0.1% of Livforsakringsbolaget Skandia Omsesidigt’s portfolio, making the stock its 9th largest position. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Intuitive Surgical were worth $64,787,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ISRG. Chilton Capital Management LLC grew its stake in Intuitive Surgical by 614.3% during the 1st quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 43 shares during the last quarter. Global Financial Private Client LLC grew its position in Intuitive Surgical by 253.3% during the 1st quarter. Global Financial Private Client LLC now owns 53 shares of the medical equipment provider’s stock worth $26,000 after purchasing an additional 38 shares during the period. Elite Financial Inc. acquired a new stake in Intuitive Surgical during the 1st quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new stake in Intuitive Surgical during the 1st quarter worth about $30,000. Finally, TD Capital Management LLC grew its position in Intuitive Surgical by 300.0% during the 1st quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider’s stock worth $30,000 after purchasing an additional 45 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.5%

ISRG stock opened at $433.99 on Tuesday. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $616.00. The stock has a market cap of $155.58 billion, a price-to-earnings ratio of 60.53, a PEG ratio of 4.71 and a beta of 1.61. The business’s 50-day moving average is $483.65 and its 200 day moving average is $506.85.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last posted its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The company had revenue of $2.44 billion for the quarter, compared to analysts’ expectations of $2.35 billion. During the same period in the previous year, the firm posted $1.78 EPS. Intuitive Surgical’s revenue was up 21.4% compared to the same quarter last year. As a group, equities analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the firm’s stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company’s stock, valued at $173,845.44. This trade represents a 92.73% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 336 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The stock was sold at an average price of $470.11, for a total transaction of $157,956.96. Following the completion of the transaction, the director directly owned 1,074 shares in the company, valued at $504,898.14. This trade represents a 23.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 45,224 shares of company stock valued at $21,716,492 in the last ninety days. 0.70% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several brokerages have weighed in on ISRG. Piper Sandler reaffirmed an “overweight” rating and set a $595.00 price target (up from $575.00) on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Evercore ISI increased their price target on Intuitive Surgical from $470.00 to $550.00 and gave the stock an “in-line” rating in a research report on Tuesday, July 8th. Citigroup reaffirmed a “buy” rating and set a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research report on Thursday, May 22nd. Truist Financial increased their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a “buy” rating in a research report on Wednesday, July 23rd. Finally, Erste Group Bank reaffirmed a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Thirteen analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus target price of $595.95.

View Our Latest Stock Report on Intuitive Surgical

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Further Reading

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report).